Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation

Psoriasis is a chronic skin disease characterized by hyperproliferation of keratinocytes and excessive inflammation. Plant-derived nanoparticles (pdNPs) are promising agents for treating inflammatory skin diseases. In this study, we examined the characteristics and functions of rose hip-derived nanoparticles (RNPs) rich in various bioactive compounds. RNPs were isolated from rose hips using sucrose ultracentrifugation and characterized using NanoSight and transmission electron microscopy. Cellular uptake by HaCaT human keratinocytes was analyzed using flow cytometry and confocal microscopy. Uptake mechanisms were investigated using siRNA knockdown. Proliferation, apoptosis, and cytokine expression were evaluated in a HaCaT psoriasis model. Antioxidant activity was assessed by measuring reactive oxygen species (ROS) levels in stimulated HaCaT and RAW264.7 mouse macrophage-like cells. The in vivo efficacy was evaluated in a mouse model of psoriasis via intradermal injection of RNPs. The RNPs obtained via ultracentrifugation exhibited a vesicular structure of approximately 100 nm in diameter. They were efficiently taken up by HaCaT cells and inhibited excessive inflammation-induced proliferation. RNPs reduced the mRNA levels of the inflammatory cytokines, interleukin-1β and interferon-γ. Additionally, RNPs were efficiently internalized by mouse macrophage-like RAW264.7 cells, decreasing the intracellular reactive oxygen species levels. The intradermal injection of RNPs effectively suppressed epidermal hyperproliferation and macrophage infiltration in an imiquimod-induced psoriasis mouse model. Collectively, these results suggest that RNPs can be used to treat psoriasis by regulating oxidative stress and inhibiting epidermal hyperproliferation. RNPs, which exerted potent effects on epidermal cells, target key pathological mechanisms such as oxidative stress and immune-driven keratinocyte proliferation. Therefore, they are promising natural therapeutic agents for psoriasis.

Authors

Institutions

Publication Details

Journal
ACS Biomaterials Science & Engineering
Published
2025-09-26
DOI
https://doi.org/10.1021/acsbiomaterials.5c00826
Citations
1
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation

Katsuhiko Yajima, Kosuke Kusamori, Shoko Itakura, Makiya Nishikawa et al.
1 citations
ACS Biomaterials Science & Engineering
Psoriasis: Treatment and Pathogenesis
0.80
article

Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation

Katsuhiko Yajima, Kosuke Kusamori, Shoko Itakura, Makiya Nishikawa, Hiroaki Todo, Shinichiro Hayashi, Masahiro Hashimoto, S Mitsuhashi
article en
1 citations

Abstract

Psoriasis is a chronic skin disease characterized by hyperproliferation of keratinocytes and excessive inflammation. Plant-derived nanoparticles (pdNPs) are promising agents for treating inflammatory skin diseases. In this study, we examined the characteristics and functions of rose hip-derived nanoparticles (RNPs) rich in various bioactive compounds. RNPs were isolated from rose hips using sucrose ultracentrifugation and characterized using NanoSight and transmission electron microscopy. Cellular uptake by HaCaT human keratinocytes was analyzed using flow cytometry and confocal microscopy. Uptake mechanisms were investigated using siRNA knockdown. Proliferation, apoptosis, and cytokine expression were evaluated in a HaCaT psoriasis model. Antioxidant activity was assessed by measuring reactive oxygen species (ROS) levels in stimulated HaCaT and RAW264.7 mouse macrophage-like cells. The in vivo efficacy was evaluated in a mouse model of psoriasis via intradermal injection of RNPs. The RNPs obtained via ultracentrifugation exhibited a vesicular structure of approximately 100 nm in diameter. They were efficiently taken up by HaCaT cells and inhibited excessive inflammation-induced proliferation. RNPs reduced the mRNA levels of the inflammatory cytokines, interleukin-1β and interferon-γ. Additionally, RNPs were efficiently internalized by mouse macrophage-like RAW264.7 cells, decreasing the intracellular reactive oxygen species levels. The intradermal injection of RNPs effectively suppressed epidermal hyperproliferation and macrophage infiltration in an imiquimod-induced psoriasis mouse model. Collectively, these results suggest that RNPs can be used to treat psoriasis by regulating oxidative stress and inhibiting epidermal hyperproliferation. RNPs, which exerted potent effects on epidermal cells, target key pathological mechanisms such as oxidative stress and immune-driven keratinocyte proliferation. Therefore, they are promising natural therapeutic agents for psoriasis.

ACS Biomaterials Science & EngineeringVol. 11(10)
Tokyo Institute of Technology (JP), Tokyo University of Science (JP), Josai University (JP)
Openalex Percentile: Top 23%
Psoriasis: Treatment and Pathogenesis
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.